Read about the latest insights in skin cancer care with a new whitepaper on advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma. View the complimentary resource today!
Joel M. Gelfand, MD, MSCE; Leonard Calabrese, DO; Adam S. Cheifetz, MD; and Stephen B. Hanauer, MD, joined together in a roundtable discussion to look at the future of immune-mediated inflammatory diseases.
Joel M. Gelfand, MD, MSCE; Leonard Calabrese, DO; Adam S. Cheifetz, MD; and Stephen B. Hanauer, MD, joined together in a roundtable discussion to look at the future of immune-mediated inflammatory diseases.
The ability of this technology to influence the skin microbiome, selectively kill cancer cells, and induce tissue or skin regeneration may give dermatologists a tool that could have a major impact on the treatment of skin disorders.
The ability of this technology to influence the skin microbiome, selectively kill cancer cells, and induce tissue or skin regeneration may give dermatologists a tool that could have a major impact on the treatment of skin disorders.
Researchers aimed to investigate this connection by examining the levels of IL-9 and its receptor in patients with psoriasis vulgaris and metabolic syndrome.
Researchers aimed to investigate this connection by examining the levels of IL-9 and its receptor in patients with psoriasis vulgaris and metabolic syndrome.
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...